JR
Julie Rubinstein (President and COO) filed 23 Form 4 reports in the trailing twelve months (0 purchases, 23 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $2.3M of ADPT (174,303 sh across 4 lots, as filed), executed Mar 11. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
23
0 buys · 23 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$21.0M
shares × price, as filed
Last traded
Nov 6
Filed yesterday
Median ADV $72.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $21.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
23 filings
Sector per market data · by filing · past 12 months
Most traded names
ADPTRecent filings
ADPTSALE
Adaptive Biotechnologies Corporation
View filing →
$844K31,662 sh across 5 lots
Exec Nov 4
Filed Nov 6 · 7:24 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $795K
30,663 sh across 3 lots
Exec Oct 30
Filed Nov 3 · 7:51 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $913K
32,443 sh across 3 lots
Exec Oct 27
Filed Oct 29 · 7:52 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $766K
30,565 sh across 4 lots
Exec Oct 22
Filed Oct 26 · 6:52 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $877K
35,543 sh across 4 lots
Exec Oct 19
Filed Oct 21 · 6:36 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $890K
35,343 sh across 4 lots
Exec Oct 14
Filed Oct 16 · 7:21 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $849K
32,943 sh across 3 lots
Exec Oct 9
Filed Oct 13 · 7:05 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $875K
33,143 sh across 3 lots
Exec Oct 6
Filed Oct 8 · 6:54 PM ET More filings →